Robert A. Grant

Robert A. Grant

Auto-generated profile, based on publicly available information

Robert A. Grant

Department of Biology, Massachusetts Institute of Technology

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2010 in Protein Science
Verified
Journal Article
Open access
PDF file
EFEmiko Fire
Emiko Fire
SGStefano V. Gullá
Stefano V. Gullá
RGRobert A. Grant
Robert A. Grant
AKAmy E. Keating
Amy E. Keating
Mcl‐1 is an antiapoptotic Bcl‐2‐family protein that protects cells against death. Structures of Mcl‐1, and of other anti‐apoptotic Bcl‐2 proteins, reveal a surface groove into which the α‐helical BH3 regions of certain proapoptotic proteins can bind. Despite high overall structural conservation, differences in this groove afford binding specificity that is important for the mechanism of Bcl‐2 family function. We report the crystal structure of human Mcl‐1 bound to a BH3 peptide derived from human Bim and the structures for three complexes that accommodate large physicochemical changes at conserved Bim sites. The mutations had surprisingly modest effects on complex stability, and the structures show that Mcl‐1 can undergo small changes to accommodate the mutant ligands. For example, a shift in a leucine side chain fills a hole left by an isoleucine‐to‐alanine mutation at the first hydrophobic buried position of Bim BH3. Larger changes are also observed, with shifting of helix α3 accommodating an isoleucine‐to‐tyrosine mutation at this same position. We surveyed the variation in available Mcl‐1 and Bcl‐xL structures and observed moderate flexibility that is likely critical for facilitating interactions of diverse BH3‐only proteins with Mcl‐1. With the antiapoptotic Bcl‐2 family members attracting significant attention as therapeutic targets, these structures contribute to our growing understanding of how specificity is achieved and can help to guide the design of novel inhibitors that target Mcl‐1.

24 November 2020 in Molecular Microbiology
Verified
Journal Article
Closed access
PDF file
GMGina D. Mawla
Gina D. Mawla
BHBranwen M. Hall
Branwen M. Hall
GCGerardo Cárcamo‐Oyarce
Gerardo Cárcamo‐Oyarce
RGRobert A. Grant
Robert A. Grant
JZJia Jia Zhang
Jia Jia Zhang
TBTania A. Baker
Tania A. Baker

25 January 2022 in eLife
Verified
Journal Article
Open access
THTheresa Hwang
Theresa Hwang
SPSara S Parker
Sara S Parker
SHSamantha M Hill
Samantha M Hill
RGRobert A Grant
Robert A Grant
MIMeucci W Ilunga
Meucci W Ilunga
AKAmy E Keating
Amy E Keating
The human proteome is replete with short linear motifs (SLiMs) of four to six residues that are critical for protein-protein interactions, yet the importance of the sequence surrounding such motifs is underexplored. We devised a proteomic screen to examine the influence of SLiM sequence context on protein-protein interactions. Focusing on the EVH1 domain of human ENAH, an actin regulator that is highly expressed in invasive cancers, we screened 36-residue proteome-derived peptides and discovered new interaction partners of ENAH and diverse mechanisms by which context influences binding. A pocket on the ENAH EVH1 domain that has diverged from other Ena/VASP paralogs recognizes extended SLiMs and favors motif-flanking proline residues. Many high-affinity ENAH binders that contain two proline-rich SLiMs use a noncanonical site on the EVH1 domain for binding and display a thermodynamic signature consistent with the two-motif chain engaging a single domain. We also found that photoreceptor cilium actin regulator (PCARE) uses an extended 23-residue region to obtain a higher affinity than any known ENAH EVH1-binding motif. Our screen provides a way to uncover the effects of proteomic context on motif-mediated binding, revealing diverse mechanisms of control over EVH1 interactions and establishing that SLiMs can’t be fully understood outside of their native context.

2 December 2021 in eLife
Verified
Journal Article
Open access
THTheresa Hwang
Theresa Hwang
SPSara S Parker
Sara S Parker
SHSamantha M Hill
Samantha M Hill
MIMeucci W Ilunga
Meucci W Ilunga
RGRobert A Grant
Robert A Grant
AKAmy E Keating
Amy E Keating
Metazoan proteomes contain many paralogous proteins that have evolved distinct functions. The Ena/VASP family of actin regulators consists of three members that share an EVH1 interaction domain with a 100 % conserved binding site. A proteome-wide screen revealed photoreceptor cilium actin regulator (PCARE) as a high-affinity ligand for ENAH EVH1. Here, we report the surprising observation that PCARE is ~100-fold specific for ENAH over paralogs VASP and EVL and can selectively bind ENAH and inhibit ENAH-dependent adhesion in cells. Specificity arises from a mechanism whereby PCARE stabilizes a conformation of the ENAH EVH1 domain that is inaccessible to family members VASP and EVL. Structure-based modeling rapidly identified seven residues distributed throughout EVL that are sufficient to differentiate binding by ENAH vs. EVL. By exploiting the ENAH-specific conformation, we rationally designed the tightest and most selective ENAH binder to date. Our work uncovers a conformational mechanism of interaction specificity that distinguishes highly similar paralogs and establishes tools for dissecting specific Ena/VASP functions in processes including cancer cell invasion.

2 August 2021 in Organic & Biomolecular Chemistry
Verified
Journal Article
Open access
PDF file
DHDavid Hymel
David Hymel
KTKohei Tsuji
Kohei Tsuji
RGRobert A. Grant
Robert A. Grant
RCRamesh M. Chingle
Ramesh M. Chingle
DKDominique L. Kunciw
Dominique L. Kunciw
Terrence R. Burke, Jr.Terrence R. Burke, Jr.
Terrence R. Burke, Jr.
A novel macrocyclic peptide strategy utilizing a glutamic acid analog that can work as an alkylated histidine replacement.